124 related articles for article (PubMed ID: 32114530)
1. Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin.
Sandhu N; Benson KRK; Kumar KA; Eyben RV; Chang DT; Gibbs IC; Hancock SL; Meola A; Chang SD; Li G; Hayden-Gephart M; Soltys SG; Pollom EL
J Neurosurg Spine; 2020 Mar; 33(1):87-94. PubMed ID: 32114530
[TBL] [Abstract][Full Text] [Related]
2. The impact of decompression with instrumentation on local failure following spine stereotactic radiosurgery.
Miller JA; Balagamwala EH; Berriochoa CA; Angelov L; Suh JH; Benzel EC; Mohammadi AM; Emch T; Magnelli A; Godley A; Qi P; Chao ST
J Neurosurg Spine; 2017 Oct; 27(4):436-443. PubMed ID: 28731393
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
[TBL] [Abstract][Full Text] [Related]
4. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
5. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated Stereotactic Radiation Therapy for Intact Brain Metastases in 5 Daily Fractions: Effect of Dose on Treatment Response.
Myrehaug S; Hudson J; Soliman H; Ruschin M; Tseng CL; Detsky J; Husain Z; Keith J; Atenafu EG; Maralani P; Heyn C; Das S; Lipsman N; Sahgal A
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):342-350. PubMed ID: 34537313
[TBL] [Abstract][Full Text] [Related]
7. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
8. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
9. Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy.
Benson KRK; Sandhu N; Zhang C; Ko R; Toesca DAS; Lee PE; Von Eyben R; Diehn M; Gensheimer M; Maxim PG; Bush K; Loo BW; Soltys SG; Pollom EL; Chang DT
Am J Clin Oncol; 2021 Nov; 44(11):559-564. PubMed ID: 34534143
[TBL] [Abstract][Full Text] [Related]
10. Spine stereotactic radiosurgery for the treatment of multiple myeloma.
Miller JA; Balagamwala EH; Chao ST; Emch T; Suh JH; Djemil T; Angelov L
J Neurosurg Spine; 2017 Mar; 26(3):282-290. PubMed ID: 27791828
[TBL] [Abstract][Full Text] [Related]
11. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.
Sharma M; Bennett EE; Rahmathulla G; Chao ST; Koech HK; Gregory SN; Emch T; Magnelli A; Meola A; Suh JH; Angelov L
Neurosurg Focus; 2017 Jan; 42(1):E14. PubMed ID: 28041323
[TBL] [Abstract][Full Text] [Related]
12. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
[TBL] [Abstract][Full Text] [Related]
13. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
15. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Radiosurgery for Patients with Spinal Metastases from Thyroid Cancer: A 20-Year Experience.
Taori S; Adida S; Tang A; Rajan A; Sefcik RK; Burton SA; Flickinger JC; Gerszten PC
World Neurosurg; 2024 May; 185():e653-e661. PubMed ID: 38412942
[TBL] [Abstract][Full Text] [Related]
17. Importance of Cobalt-60 Dose Rate and Biologically Effective Dose on Local Control for Intracranial Meningiomas Treated With Stereotactic Radiosurgery.
Huo M; Rose M; van Prooijen M; Cusimano MD; Laperriere N; Heaton R; Gentili F; Payne D; Shultz DB; Kongkham P; Kalia SK; Schwartz M; Bernstein M; Spears J; Zadeh G; Hodaie M; Tsang DS
Neurosurgery; 2022 Jan; 90(1):140-147. PubMed ID: 34982881
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes.
Bernard V; Bishop AJ; Allen PK; Amini B; Wang XA; Li J; Tatsui CE; Rhines LD; Brown PD; Ghia AJ
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1207-1215. PubMed ID: 29029886
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
Helou J; Thibault I; Poon I; Chiang A; Jain S; Soliman H; Erler D; Yeung L; Cheung P
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):419-427. PubMed ID: 28463162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
